Skip to main content

Search

5 result(s) for 'author#Stéphane Oudard' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Following publication of the original article [1], the authors reported that authors’ given and family names haven been incorrectly tagged.

    Authors: Anastasia Saade, Audrey Mansuet-Lupo, Jennifer Arrondeau, Constance Thibault, Mariana Mirabel, François Goldwasser, Stéphane Oudard and Laurence Weiss
    Citation: Journal for ImmunoTherapy of Cancer 2019 7:335
    Content type: Correction Published on:

    The original article was published in Journal for ImmunoTherapy of Cancer 2019 7:266

  2. This study aims to better define prognostic factors for patients with metastatic urothelial carcinoma (mUC), and to identify patients who will benefit from first-line cisplatin-based chemotherapy. We test the ...

    Authors: Guilhem Roubaud, Véronique Brouste, Phillipe Beuzeboc, Aude Fléchon, Diego Tosi, Sandrine Lavau-Denes, Christine Chevreau, Stéphane Culine, Stéphane Oudard, Amandine Quivy, Philippe Pourquier and Nadine Houédé
    Citation: Journal of Negative Results in BioMedicine 2015 14:18
    Content type: Research Published on:

  3. Our group has previously shown that EPHRIN-A1 and SCINDERIN expression by tumor cells rendered them resistant to cytotoxic T lymphocyte-mediated lysis. Whereas the prognostic value of EPHRIN-A1 expression in c...

    Authors: Meriem Hasmim, Cécile Badoual, Philippe Vielh, Françoise Drusch, Virginie Marty, Agnès Laplanche, Mariana de Oliveira Diniz, Hélène Roussel, Eléonore De Guillebon, Stéphane Oudard, Stéphane Hans, Eric Tartour and Salem Chouaib
    Citation: BMC Cancer 2013 13:592
    Content type: Research article Published on:

  4. Nivolumab, a programmed death-1 (PD-1) inhibitor, is an immune checkpoint inhibitor particularly used in the treatment of malignant melanoma, non-small cell lung cancer and renal cell carcinoma. Immune-related...

    Authors: Anastasia Saade, Audrey Mansuet-Lupo, Jennifer Arrondeau, Constance Thibault, Mariana Mirabel, François Goldwasser, Stéphane Oudard and Laurence Weiss
    Citation: Journal for ImmunoTherapy of Cancer 2019 7:266
    Content type: Case report Published on:

    The Correction to this article has been published in Journal for ImmunoTherapy of Cancer 2019 7:335

  5. COU-AA-301 trial has proved that abiraterone acetate (AA), a selective inhibitor of androgen biosynthesis, improved overall survival (OS) of patients with metastatic castration resistant prostate cancer (mCRPC...

    Authors: Nadine Houédé, Philippe Beuzeboc, Sophie Gourgou, Diego Tosi, Laura Moise, Gwenaëlle Gravis, Remy Delva, Aude Fléchon, Igor Latorzeff, Jean-Marc Ferrero, Stéphane Oudard, Sophie Tartas, Brigitte Laguerre, Delphine Topart, Guilhem Roubaud, Hanane Agherbi…
    Citation: BMC Cancer 2015 15:222
    Content type: Research article Published on: